Although the 2018 U.S. stroke guidelines recommended extending the window for endovascular thrombectomy (EVT) to 24 hours in select stroke patients, a new meta-analysis in JAMA Neurology serves as a reminder that prompt treatment remains crucial for achieving successful reperfusion.

A single-center study with more than a decade of follow-up supports the long-term efficacy of patent foramen ovale (PFO) closure for the prevention of recurrent ischemic events, showing only 1 percent of patients had an ischemic stroke and 2.9 percent experienced a transient ischemic attack.

Aspirin offers modest protection against cardiovascular events in primary prevention, but that benefit is at least partially offset by an increase in major bleeding events, according to a meta-analysis published Jan. 22 in JAMA.

Royal Philips and the American Heart Association are collaborating for a new program devoted to increasing survival rates in patients who experience sudden cardiac arrest (SCA), the organizations announced Jan. 23.

Higher concentrations of troponin—even those that were within a “normal range”—signal increased odds of adverse outcomes among outpatients with stable chest pain, suggesting the biomarker test may improve risk stratification and inform management strategies for this common clinical scenario.

Just 21 percent of adults and 17 percent of children and adolescents living with type 1 diabetes (T1D) meet the treatment goals outlined by the American Diabetes Association, according to a study published Jan. 18 in Diabetes Technology & Therapeutics.

LEIPZIG and MARLBOROUGH, Mass. (January 22, 2019) — Boston Scientific (NYSE: BSX) today announced diabetic subanalysis results from the IMPERIAL trial in which patients treated with the ELUVIA™ Drug-Eluting Vascular Stent System demonstrated statistically significant lower rates of target lesion revascularization (TLR) and stent thrombosis when compared to those treated with the Zilver® PTX® Drug-Eluting Peripheral Stent. 

A study of more than 1,000 Hispanic adults with hypertension found increased health literacy improves patients’ adherence to blood pressure medications—but the majority of the population struggles with poor health literacy, indicating a need for tailored interventions.